However, we now have found that the amplification of these two genes only appeared at the later stages of MTX-resistance, which suggests that DHFR and MSH3 amplification could be a selected mechanism of cancer cells to adapt to higher concentrations of MTX. The gene discussed is DHFR; the disease is cancer.